Human cytomegalovirus infection promotes rapid maturation of NK cells expressing activating killer Ig-like receptor in patients transplanted with NKG2C-/- umbilical cord blood

Journal of Immunology

Volumn 192, Issue 4, 2014, Pages 1471-1479

  Della Chiesa, Mariella ^a   Falco, Michela ^b   Bertaina, Alice ^c   Muccio, Letizia ^a   Alicata, Claudia ^a   Frassoni, Francesco ^b   Locatelli, Franco ^c,d   Moretta, Lorenzo ^b   Moretta, Alessandro ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ADULT; ARTICLE; CELL EXPANSION; CELL FUNCTION; CELL MATURATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOMEGALOVIRUS INFECTION; DEGRANULATION; DOWN REGULATION; GENE; GENE DELETION; GRAFT RECIPIENT; HEMATOLOGIC MALIGNANCY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; NATURAL KILLER CELL; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; NKG2C GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL CORD BLOOD;

ADULT; ANTIGENS, CD56; CELL DIFFERENTIATION; CHILD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FETAL BLOOD; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERFERON-GAMMA; KILLER CELLS, NATURAL; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; RECEPTORS, KIR; RECEPTORS, KIR2DL2; RECEPTORS, KIR2DL3; RECEPTORS, KIR3DL1; RECEPTORS, KIR3DS1;

EID: 84896716290     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302053     Document Type: Article

References (45)

1. Moretta, A., C. Bottino, M. Vitale, D. Pende, R. Biassoni, M. C. Mingari, and L. Moretta. 1996. Receptors for HLA class-I molecules in human natural killer cells. Annu. Rev. Immunol. 14: 619-648.
2. Moretta, A., C. Bottino, M. Vitale, D. Pende, C. Cantoni, M. C. Mingari, R. Biassoni, and L. Moretta. 2001. Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19: 197-223.
3. Lanier, L. L. 1998. NK cell receptors. Annu. Rev. Immunol. 16: 359-393.
4. Parham, P. 2005. MHC class I molecules and KIRs in human history, health and survival. Nat. Rev. Immunol. 5: 201-214.
5. Braud, V. M., D. S. J. Allan, C. A. O'Callaghan, K. Söderström, A. D'Andrea, G. S. Ogg, S. Lazetic, N. T. Young, J. I. Bell, J. H. Phillips, et al. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391: 795-799.
6. Moretta, A., S. Sivori, M. Vitale, D. Pende, L. Morelli, R. Augugliaro, C. Bottino, and L. Moretta. 1995. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells. J. Exp. Med. 182: 875-884.
7. Chewning, J. H., C. N. Gudme, K. C. Hsu, A. Selvakumar, and B. Dupont. 2007. KIR2DS1-positive NK cells mediate alloresponse against the C2 HLA-KIR ligand group in vitro. J. Immunol. 179: 854-868.
8. Graef, T., A. K. Moesta, P. J. Norman, L. Abi-Rached, L. Vago, A. M. Older Aguilar, M. Gleimer, J. A. Hammond, L. A. Guethlein, D. A. Bushnell, et al. 2009. KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A*11 while diminishing avidity for HLA-C. J. Exp. Med. 206: 2557-2572.
9. Hsu, K. C., X. R. Liu, A. Selvakumar, E. Mickelson, R. J. O'Reilly, and B. Dupont. 2002. Killer Ig-like receptor haplotype analysis by gene content: evidence for genomic diversity with a minimum of six basic framework haplotypes, each with multiple subsets. J. Immunol. 169: 5118-5129.
10. Gumá, M., A. Angulo, C. Vilches, N. Gómez-Lozano, N. Malats, and M. López-Botet. 2004. Imprint of human cytomegalovirus infection on the NK cell receptor repertoire. Blood 104: 3664-3671.
11. Gumá, M., C. Cabrera, I. Erkizia, M. Bofill, B. Clotet, L. Ruiz, and M. López-Botet. 2006. Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/NKG2C receptor in aviremic HIV-1-positive patients. J. Infect. Dis. 194: 38-41.
12. Brunetta, E., M. Fogli, S. Varchetta, L. Bozzo, K. L. Hudspeth, E. Marcenaro, A. Moretta, and D. Mavilio. 2010. Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus coinfection. AIDS 24: 27-34.
13. Petitdemange, C., P. Becquart, N. Wauquier, V. Béziat, P. Debré, E. M. Leroy, and V. Vieillard. 2011. Unconventional repertoire profile is imprinted during acute chikungunya infection for natural killer cells polarization toward cytotoxicity. PLoS Pathog. 7: e1002268.
14. Björkström, N. K., T. Lindgren, M. Stoltz, C. Fauriat, M. Braun, M. Evander, J. Michaëlsson, K. J. Malmberg, J. Klingström, C. Ahlm, and H. G. Ljunggren. 2011. Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J. Exp. Med. 208: 13-21.
15. + NK cells expressing self-specific KIRs in chronic hepatitis patients. Eur. J. Immunol. 42: 447-457.
16. + NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 107: 3624-3631.
17. Della Chiesa, M., M. Falco, M. Podestà, F. Locatelli, L. Moretta, F. Frassoni, and A. Moretta. 2012. Phenotypic and functional heterogeneity of human NK cells developing after umbilical cord blood transplantation: a role for human cytomegalovirus? Blood 119: 399-410.
18. + natural killer cells with potent function. Blood 119: 2665-2674.
19. Brunetta, E., M. Fogli, S. Varchetta, L. Bozzo, K. L. Hudspeth, E. Marcenaro, A. Moretta, and D. Mavilio. 2009. The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer-cell subsets associated with high levels of HIV-1 viremia. Blood 114: 3822-3830.
20. + NK cells are transplantable and expand in vivo in response to recipient CMV antigen. J. Immunol. 189: 5082-5088.
21. Kuijpers, T. W., P. A. Baars, C. Dantin, M. van den Burg, R. A. van Lier, and E. Roosnek. 2008. Human NK cells can control CMV infection in the absence of T cells. Blood 112: 914-915.
22. Hikami, K., N. Tsuchiya, T. Yabe, and K. Tokunaga. 2003. Variations of human killer cell lectin-like receptors: common occurrence of NKG2-C deletion in the general population. Genes Immun. 4: 160-167.
23. Moraru, M., M. Cañizares, A. Muntasell, R. de Pablo, M. López-Botet, and C. Vilches. 2012. Assessment of copy-number variation in the NKG2C receptor gene in a single-tube and characterization of a reference cell panel, using standard polymerase chain reaction. Tissue Antigens 80: 184-187.
24. Miyashita, R., N. Tsuchiya, K. Hikami, K. Kuroki, T. Fukazawa, M. Bijl, C. G. Kallenberg, H. Hashimoto, T. Yabe, and K. Tokunaga. 2004. Molecular genetic analyses of human NKG2C (KLRC2) gene deletion. Int. Immunol. 16: 163-168.
25. Frassoni, F., F. Gualandi, M. Podestà, A. M. Raiola, A. Ibatici, G. Piaggio, M. Sessarego, N. Sessarego, M. Gobbi, N. Sacchi, et al. 2008. Direct intrabone transplant of unrelated cord-blood cells in acute leukaemia: a phase I/II study. Lancet Oncol. 9: 831-839.
26. Béziat, V., B. Descours, C. Parizot, P. Debré, and V. Vieillard. 2010. NK cell terminal differentiation: correlated stepwise decrease of NKG2A and acquisition of KIRs. PLoS ONE 5: e11966.
27. dim NK-cell differentiation uncoupled from NK-cell education. Blood 116: 3853-3864.
28. Pende, D., S. Marcenaro, M. Falco, S. Martini, M. E. Bernardo, D. Montagna, E. Romeo, C. Cognet, M. Martinetti, R. Maccario, et al. 2009. Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity. Blood 113: 3119-3129.
29. Fauriat, C., M. A. Ivarsson, H. G. Ljunggren, K. J. Malmberg, and J. Michaëlsson. 2010. Education of human natural killer cells by activating killer cell immunoglobulin-like receptors. Blood 115: 1166-1174.
30. Muntasell, A., C. Vilches, A. Angulo, and M. López-Botet. 2013. Adaptive reconfiguration of the human NK-cell compartment in response to cytomegalovirus: a different perspective of the host-pathogen interaction. Eur. J. Immunol. 43: 1133-1141.
31. Malmberg, K. J., V. Beziat, and H. G. Ljunggren. 2012. Spotlight on NKG2C and the human NK-cell response to CMV infection. Eur. J. Immunol. 42: 3141-3145.
32. hi natural killer cell subset during acute human cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 108: 14725-14732.
33. + subset in a patient with atypical Janus kinase 3-deficient severe combined immunodeficiency. J. Allergy Clin. Immunol. 131: 1230-1233.e2.
34. Béziat, V., L. L. Liu, J. A. Malmberg, M. A. Ivarsson, E. Sohlberg, A. T. Björklund, C. Retière, E. Sverremark-Ekström, J. Traherne, P. Ljungman, et al. 2013. NK cell responses to cytomegalovirus infection lead to stable imprints in the human KIR repertoire and involve activating KIRs. Blood 121: 2678-2688.
35. Tortorella, D., B. E. Gewurz, M. H. Furman, D. J. Schust, and H. L. Ploegh. 2000. Viral subversion of the immune system. Annu. Rev. Immunol. 18: 861-926.
36. Khakoo, S. I., and M. Carrington. 2006. KIR and disease: a model system or system of models? Immunol. Rev. 214: 186-201.
37. Martin, M. P., X. Gao, J. H. Lee, G. W. Nelson, R. Detels, J. J. Goedert, S. Buchbinder, K. Hoots, D. Vlahov, J. Trowsdale, et al. 2002. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31: 429-434.
38. Stern, M., H. Elsässer, G. Hönger, J. Steiger, S. Schaub, and C. Hess. 2008. The number of activating KIR genes inversely correlates with the rate of CMV infection/reactivation in kidney transplant recipients. Am. J. Transplant. 8: 1312-1317.
39. Stern, M., K. Hadaya, G. Hönger, P. Y. Martin, J. Steiger, C. Hess, and J. Villard. 2011. Telomeric rather than centromeric activating KIR genes protect from cytomegalovirus infection after kidney transplantation. Am. J. Transplant. 11: 1302-1307.
40. Cook, M., D. Briggs, C. Craddock, P. Mahendra, D. Milligan, C. Fegan, P. Darbyshire, S. Lawson, E. Boxall, and P. Moss. 2006. Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation. Blood 107: 1230-1232.
41. Zaia, J. A., J. Y. Sun, G. M. Gallez-Hawkins, L. Thao, A. Oki, S. F. Lacey, A. Dagis, J. Palmer, D. J. Diamond, S. J. Forman, and D. Senitzer. 2009. The effect of single and combined activating killer immunoglobulin-like receptor genotypes on cytomegalovirus infection and immunity after hematopoietic cell transplantation. Biol. Blood Marrow Transplant. 15: 315-325.
42. Sun, J. C., J. N. Beilke, and L. L. Lanier. 2009. Adaptive immune features of natural killer cells. Nature 457: 557-561.
43. Sun, J. C., S. Lopez-Verges, C. C. Kim, J. L. DeRisi, and L. L. Lanier. 2011. NK cells and immune "memory". J. Immunol. 186: 1891-1897.
44. Thomas, R., H. Z. Low, K. Kniesch, R. Jacobs, R. E. Schmidt, and T. Witte. 2012. NKG2C deletion is a risk factor of HIV infection. AIDS Res. Hum. Retroviruses 28: 844-851.
45. Noyola, D. E., C. Fortuny, A. Muntasell, A. Noguera-Julian, C. Muñoz-Almagro, A. Alarcón, T. Juncosa, M. Moraru, C. Vilches, and M. López-Botet. 2012. Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children. Eur. J. Immunol. 42: 3256-3266.